RHO and retinitis pigmentosa 1: Recently, Wu et al. also treated a novel humanized mouse model of C110R rhodopsin-linked RP with ablate-and-replace, establishing further proof of concept and highlighting this strategy’s ability to treat multiple pathogenic mutations with a single therapeutic (60).